top of page

News & Insights
Search


If your AI remembers too much, it might break the law: Germany’s GEMA v. OpenAI ruling & What life sciences should know about AI copyright risk
If your company is building its own large language model (LLM) for applications like drug discovery, biomarker identification, or clinical trial optimization, this case should be on your radar. A recent ruling by the Munich Regional Court (LG München v. 11.11.2025 – 42 O 14139/24 – GEMA vs. Open AI) —while not yet legally binding—sends a clear signal: training LLMs on protected works constitutes copyright infringement under German law, unless narrow legal exceptions apply . T
2 days ago


Understanding licensing in Life Sciences: What Matters to Different Stakeholders
Licensing is one of the most powerful tools in the life sciences industry - yet no two deals look the same. Whether you’re a biotech...
Feb 2


10 Tips for Better CDAs (Part 2)
Last week, we gave you five tips on how to improve your confidential disclosure agreements ( "10 Tips for Better CDAs (Part 1)" ). Here...
Dec 29, 2024


10 Tips for Better CDAs (Part 1)
A Confidential Disclosure Agreement (CDA) is one of the most widely-used agreements in the life sciences sector. It is also an important...
Dec 22, 2024
bottom of page
